Potential role of anti-idiotype antibodies in active tumor immunotherapy
- 1 January 1989
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 9 (2) , 109-124
- https://doi.org/10.1016/s1040-8428(89)80007-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Idiotypic Manipulation of the Immune Response to Transplantation AntigensImmunological Reviews, 1986
- Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cellsEuropean Journal of Immunology, 1986
- Immunogenicity of melanoma‐associated gangliosides in cancer patientsInternational Journal of Cancer, 1985
- Monoclonal Idiotope Vaccine Against Streptococcus pneumoniae InfectionScience, 1984
- Clonotypic Antibodies which Stimulate T Cell Clone ProliferationImmunological Reviews, 1984
- Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.The Journal of Experimental Medicine, 1983
- Treatment of lymphoid tumors with anti-idiotype antibodiesSpringer Seminars in Immunopathology, 1983
- Regulatory idiotypes. T helper cells recognize a shared VH idiotope on phosphorylcholine-specific antibodies.The Journal of Experimental Medicine, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Tumor‐specific T helper activity can be abrogated by two distinct suppressor cell mechanismsEuropean Journal of Immunology, 1982